Keywords: لوودوپا; Dystonia; Machado-Joseph; Levodopa; Botulinum toxin; MRI;
مقالات ISI لوودوپا (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: لوودوپا; Reduced graphene oxide; Self assembled; Gold nanoparticles; Levodopa; Uric acid; Folic acid
Keywords: لوودوپا; Levodopa; Parkinson's disease; Off period; Dry powder inhalation; Cyclops;
Keywords: لوودوپا; DA; dopamine; DHA; docosahexaenoic acid; l-DOPA; levodopa; LID; l-DOPA-induced-dyskinesias; MPTP; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; MRM; Multiple reaction monitoring; PD; Parkinson's disease; Pls; Plasmalogen; PlsEtn; Ethanolamine plasmalogens
Keywords: لوودوپا; Parkinson's disease; Levodopa; Postural control; Electrovestibulography; Symptomatology; Biomarker;
Keywords: لوودوپا; Tyrosine; Levodopa; Enzyme-induced excitation-emission-kinetic; Third-order calibration; Alternating quadrilinear decomposition
Keywords: لوودوپا; Parkinson's disease; Aging; Rodent; Grafting; Dyskinesias; Levodopa; Synaptopodin
Keywords: لوودوپا; Parkinson's disease; Levodopa; Dyskinesia; Hypokinesia; Dopamine agonists; Continuous dopaminergic stimulation;
Keywords: لوودوپا; Droxidopa; Parkinson's disease; Motor fuction; Add-on; Norepinnehrine; CGI; Clinical Global Impression rating score; FAS; full analysis set; ITT; intent-to-treat; l-DOPA; Levodopa; l-DOPS; l-threo-3,4-dihydroxyphenylserine; NE; norepinnehrine; PD; Parki
Keywords: لوودوپا; Fear extinction; Exposure therapy; Augmented relearning; Reconsolidation; Drug development; Cognitive enhancer; 5-HT; 5-hydroxytryptamine = serotonin; AC; adenylate cyclase; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; AMY; amygdala; BA;
Keywords: لوودوپا; Levodopa; Diffusion coefficient; Transport properties; Aqueous solutions
Keywords: لوودوپا; Dopamine; Immunodepression; Levodopa; Stroke recovery; T-cells
Keywords: لوودوپا; Levodopa; Parkinson's; Orthostatic intolerance; Orhostatic hypotension; Non-motor symptoms;
Keywords: لوودوپا; Peripheral neuropathy; Alpha-synuclein; Vitamin B deficiency; Levodopa;
Keywords: لوودوپا; APs; antipsychotic drugs; DAT; dopamine transporter; DIP; Drug-induced parkinsonism; DRBA; dopamine receptor blocking agents; 123I-FP-CIT SPECT; single photon emission computed tomography of dopamine transporter; PD; Parkinson's disease; UPDRS IIIÂ =Â Uni
Keywords: لوودوپا; Pseudopolymorphism; Levodopa; Hydrate
Keywords: لوودوپا; Rotigotine; Parkinson's disease; Dyskinesia; Levodopa;
Keywords: لوودوپا; Levodopa; Graphene; Ionic liquid; Electrocatalysis
Keywords: لوودوپا; Memory; Event-related potentials; Dopamine; Methylphenidate; Levodopa
Keywords: لوودوپا; Parkinson's disease; Dyskinesia; Levodopa; Motor cortex; Spine; Plasticity; Animal model; 6-Hydroxydopamine; Whole-cell patch clamp; Miniature excitatory postsynaptic currents;
Keywords: لوودوپا; Contingency management; Levodopa; Modafinil; Naltrexone; Cocaine cessation; Relapse prevention;
Keywords: لوودوپا; Ropinirole; Levodopa; Carbon nanotubes; Electrochemical sensor; Stripping analysis
Keywords: لوودوپا; Parkinson's disease; 18F-DOPA positron emission tomography; MPTP; Levodopa; Dopaminergic marker;
Keywords: لوودوپا; Neurodegeneration; Compensation; Brain; Nervous System; ANOVA; analysis of variance; CoG; center of gravity; ED; Euclidian distance; EMG; electromyography; HADS; Hospital Anxiety and Depression Scale; levodopa; L-3,4-dihydroxyphenylalanine; M1; motor cort
Keywords: لوودوپا; ACh; acetylcholine; AAV; adeno-associated virus; AgRP; agouti-related protein; ArchT; archaerhodopsin; BAC; bacterial artificial chromosomes; ChRs; channelrhodopsins; DBS; deep brain stimulation; DREADDs; designer receptors exclusively activated by design
Keywords: لوودوپا; Parkinson's disease; Pain threshold; H215O positron emission tomography; Levodopa; Neuropathic pain;
Keywords: لوودوپا; Astrocytes; Dopamine receptor; Glial cell line-derived neurotrophic factor; Glial fibrillary acidic protein; Levodopa; Stroke recovery;
Keywords: لوودوپا; Parkinson's disease; fMRI; Movement; Levodopa;
Keywords: لوودوپا; ANOVA; analyses of variance; APA; anticipatory postural adjustment; BP; bite plate; FO; foot off; H & Y; Hoehn and Yahr scale; HG; bilateral handgrip; MDS-UPDRS; Movement Disorder Society-Sponsored Unified Parkinson's Disease Rating Scale; PD; Parkinson
Keywords: لوودوپا; 6-OHDA; 6-hydroxydopamine; AA; Arachidonic; AD; Alzheimer's disease; ALA; α-linolenic acid; ApoE4; Apolipoprotein E4 allele; APP; Amyloid precursor protein; ATP; Adenosine triphosphate; Aβ; Beta-amyloid peptide; CAG; Cytosine-adenine-guanine; DHA;
Keywords: لوودوپا; COH; coherence; DBS; deep brain stimulation; iCOH; imaginary part of coherence; iCOHsig; jackknife significance of iCOH; iCOHsigav; averaged jackknife significance of iCOH; LFP; local field potentials; PD; Parkinson's disease; PSI; phase-slope index;
Keywords: لوودوپا; Anti-Parkinson drugs; Guidelines; Initial treatment; Levodopa; Parkinson's disease
Keywords: لوودوپا; Levodopa; Dopamine; Orexin; Antinociception; Colonic distension
Diffusion in ternary aqueous {L-dopaâ¯+â¯(NaSO3)n-β-cyclodextrin} solutions using the pseudo-binary approximation
Keywords: لوودوپا; Levodopa; β-Cyclodextrin sulfated sodium salt; Diffusion coefficient; Transport properties; Aqueous solutions;
Motor fluctuations and levodopa-induced dyskinesias in dopa-responsive dystonia
Keywords: لوودوپا; Levodopa; l-dopa; Dopamine-induced dyskinesia; Dyskinesia; DRD; Dopa-responsive dystonia; Dopamine; Dopamine agonist; Carbidopa-levodopa; Ropinirole; Wearing off phenomenon; DYT5; Motor fluctuation; GCH-1;
Serotonergic neurons mediate the anxiolytic effect of l-DOPA: Neuronal correlates in the amygdala
Keywords: لوودوپا; Parkinson's disease; Anxiety; Monoamines; Levodopa; Basolateral amygdala;
Exploiting second-order advantage from mathematically modeled voltammetric data for simultaneous determination of multiple antiparkinson agents in the presence of uncalibrated interference
Keywords: لوودوپا; Antiparkinson agents; Multi-way calibration; Second-order advantage; Simultaneous determination; Uncalibrated interference; PD; Parkinson's disease; DPA; dopamine; LDP; levodopa; carbidopa; CDP; MDP; methyldopa; BA; benserazide; TOL; tolcapone; ENT; entac
Garcinol, an effective monoamine oxidase-B inhibitor for the treatment of Parkinson's disease
Keywords: لوودوپا; L-deprenyl; Levodopa; Neuroprotection; Neurodegeneration; Oxidative stress;
Daily intake of Mucuna pruriens in advanced Parkinson's disease: A 16-week, noninferiority, randomized, crossover, pilot study
Keywords: لوودوپا; Parkinson's disease; Mucuna pruriens; Levodopa; Clinical trials randomized controlled (CONSORT agreement);
Mucuna pruriens (L.) DC chemo sensitize human breast cancer cells via downregulation of prolactin-mediated JAK2/STAT5A signaling
Keywords: لوودوپا; ANOVA; Analysis of variance; PRL; prolactin; PRLR; prolactin receptor; JAK2; janus kinase 2; STAT5A; signal transducer and activator of transcription 5A; LD; levodopa; MP; Mucuna pruriens (L.) DC; MTT; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
Bdnf variant is associated with milder motor symptom severity in early-stage Parkinson's disease
Keywords: لوودوپا; Brain-derived neurotrophic factor; Levodopa; Single nucleotide polymorphism; Val66Met; rs6265;
Dopamine loss alters the hippocampus-nucleus accumbens synaptic transmission in the Tg2576 mouse model of Alzheimer's disease
Keywords: لوودوپا; AAV; adeno-associated virus; aCSF; artificial cerebro-spinal fluid; AD; Alzheimer's disease; ANOVA; analysis of variance; AP; action potential; CaMKIIα; Ca2+/calmodulin-dependent protein kinase II alpha; Cm; cell capacitance; CNO; clozapine-N-oxide; DA;
Micellar HPLC-UV method for the simultaneous determination of levodopa, carbidopa and entacapone in pharmaceuticals and human plasma
Keywords: لوودوپا; Micellar liquid chromatography; Levodopa; Carbidopa; Entacapone; Human plasma;
Gait initiation is impaired in subjects with Parkinson's disease in the OFF state: Evidence from the analysis of the anticipatory postural adjustments through wearable inertial sensors
Keywords: لوودوپا; Inertial sensors; Force plate; Accelerometry; Spatio-temporal parameters; APA phases; Levodopa;
Effect of Levodopaâ+âCarbidopa on the Laryngeal Electromyographic Pattern in Parkinson Disease
Keywords: لوودوپا; Electromyography; Voice; Laryngeal muscle; Parkinson disease; Levodopa;
Liquid levodopa-carbidopa in advanced Parkinson's disease with motor complications
Keywords: لوودوپا; Parkinson's disease; Motor complications; Liquid; Levodopa; Dyskinesia;
Opposite effects of l-dopa and DBS-STN on saccadic eye movements in advanced Parkinson's disease
Keywords: لوودوپا; Saccade; Deep brain stimulation; Subthalamic nucleus; Levodopa; Parkinson's disease;
Dopamine D3 receptor-modulated neuroprotective effects of lisuride
Keywords: لوودوپا; 6-hydroxydopamine; Dopamine; D3 receptor; Lisuride; Substantia nigra; 6-OHDA; 6-hydroxydopamine; DAergic; dopaminergic; E; embryonic day; l-DOPA; levodopa; PD; Parkinson's disease; SN; substantia nigra; TEM; transmission electron microscopy; TH; tyrosine
Anhedonia Is Associated with Poorer Outcomes in Contingency Management for Cocaine Use Disorder
Keywords: لوودوپا; Contingency management; Incentives; Cocaine use disorder; Anhedonia; Levodopa; Bayesian statistics;